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Asthma, or acute reversible obstructive airways 
disease (ROAD), is a major respiratory disease af­
fecting approximately eight million people in the 
United States. The disease is characterized by attacks 
of wheezing dyspnea with coughing and sputum pro­
duction. Although most adult patients who have the 
disease demonstrate either bronchospastic episodes 
during childhood or will have repeated episodes of 
respiratory infection, upper and lower or both during 
early years, some patients do begin only in later life, 
that is, adult onset asthma. All of these patients usu­
ally have no symptoms or signs during interval peri­
ods, but with proper stimuli will demonstrate airways 
obstruction. 
The pathogenesis and pathology of asthma are 
located in the airways where there is bronchospasm 
from contraction of the circumairway smooth 
muscle, m ucosal edema, and excessive 111 ucous pro­
duction, all leading to narrowing of the airway lu­
men. These processes are initiated by the release of 
chemical medicators from pulmonary mast cells by a 
variety of stimuli. The abnormal response of the asth­
matic bronchus may be caused by an immune reac­
tion involving lgE, by infection, by certain physical 
factors including exercise and cold temperature, as 
well as by a combination of these factors and prob­
ably other unknown factors. Patients with asthma 
respond to minimal stimuli with increase in airways 
resistance indicating the presence of increased airway 
tone or ease of provocation-"twitchy airways." This 
is indicated by the smaller dose of known airway 
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constrictors necessary to produce bronchoconstric­
tion in an asthmatic than in a normal person. This 
has led to the theory of partial beta blockade. The 
sympathetic beta two receptors located in the air­
ways are bronchodilating. Inhibition or blockade 
of these receptors results in bronchoconstriction, thus 
suggesting a partial beta blockade in patients with 
asthma. Alpha sympathetic stimulation also leads to 
bronchoconstriction. This knowledge has led to the 
better understanding of the biochemical mechanisms 
of asthma and to drug therapy. Superficially, 
bronchodilation is medicated primarily by increases 
in 3, 5 cyclic AMP. Cyclic AMP production is 
increased by beta agonists, for example, ephedrine, 
isoproterenol, isoetharine, and others. Its breakdown 
is inhibited by methylxanthines, for example, ami­
nophylline. Therefore, it is very rational to treat asth­
matics with both of these classes of drugs at the 
same time (1-4). 
The diagnosis of ROAD is not difficult in the 
usual case. However, particularly in older adults, dif­
ficulty in separating other chronic airways disease, 
especially chronic bronchitis, becomes a problem. 
These two conditions frequently occur together and 
should be separated, according to the purist. From a 
practical therapeutic standpoint, it makes little differ­
ence, except from a prognostic standpoint, since 
chronic bronchitis tends to be a progressive disease 
and asthma may not be. 
The management of ROAD can be separated 
into three phases: I) Outpatient, 2) Emergency Room, 
and 3) Inpatient. The objective of therapy should be 
to avoid. if at all possible. phases two and three. 
Outpatient management should include a dili­
gent search for inciting causes of episodes, 
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particularly those avoidable irritants which must 
be isolated and removed from the patient's en­
vironment. This must include a thorough history to 
evaluate the problems of allergy, for example. pre­
vious history of allergic reactions. eczema as a child. 
recurring rhinitis, hayfever, and other factors. On 
physical examination. the presence of congested, 
bluish, nasal mucous membranes or nasal polyps 
suggests allergy. Eosinophilia in nasal or sputum 
smears or peripheral blood smears, additionally. 
suggests allergy and should be evaluated in all 
patients with ROAD. Since many parasitic diseases 
will have pulmonary involvement, the stools of 
patients with peripheral eosinophilia should be eval­
uated for ova and parasites. Most people spend more 
time in their bedroom than in any other room, thus 
attempts should be made to keep this room as dust­
and antigen-free as possible. Therefore, nonallergic 
bed covers and pillows should be used. overstuffed 
furniture, wool rugs, and draperies should be re­
moved. The room should be cleaned in the morning 
to allow dust to settle before night. No animals 
should be allowed in the bedroom. I believe that all 
patients who have a suggestion of allergy should be 
evaluated by an allergist and desensitized if indicated. 
The drug therapy of ROAD should include both 
sympathomimetics, (epinephrine, ephedrine, terbuta­
line, metaproterenol, and others) plus xanthines 
(aminophylline) for the above mentioned reasons. 
Depending upon the severity of the difficulty. the 
dosage of these drugs will need to be varied. Some 
patients will require drugs intermittently, some con­
tinuously. Since much of the problem is caused by 
excessive mucous plugging of airways (7), and 
antihistamines have a drying effect on mucous, ten­
ding to make its removal more difficult, I prefer not 
to use these drugs. Instead, these patients should be 
encouraged to force hydrate themselves to keep secre­
tions in as loose a state as possible. The use of anti­
biotics is predicated on the presence of infection 
which is best assessed by evaluation of the sputum, 
both in wet preparation and gram stains, to look for 
polys and pathogenic bacteria as well as eosinophils, 
Charcot-Leyden crystals, and Curschmann's spirals. 
Adrenal steroids should be used as the last drug when 
other drugs have failed or in patients who have been 
known to require steroids previously. Another drug 
which has outpatient application is cromolyn so­
dium. This drug has no effect in the acute attack and 
should be used only to prevent attacks. It should be 
tried in patients who have frequent bronchospastic 
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episodes or who require continuous steroids to avoid 
attacks. It must be administered four times daily 
and should be given for several weeks to assess its 
therapeutic value. The combination of the above 
modalities should be adequate to control 80% to 90% 
of all patients with ROAD. 
Most patients who arrive in the Emergency 
Room because the above regimen has failed or be­
cause they have not had proper medical supervision 
will respond to parenteral bronchodilators. However, 
arterial blood gases should be measured to evaluate 
the need for oxygen therapy. Eighty percent or more 
of these patients will have mild hypoxemia and will 
be hyperventilating, (low PaCO,) (5). If the pCO, is 
normal or elevated, this indicates a more severe state 
and such an individual should be considered under 
phase three (6 ). Either subcutaneous epinephrine 
0.3 cc, I: I 000 aqueous epinephrine or terbutaline 
0.25 mg should be given initially and may be repeated 
in 15 to 30 minutes if needed. Obviously, patients 
with cardiac disease (arrhythmia, angina, hyperten­
sion. and others) are at great risk under these condi­
tions. particularly if very hypoxemic, and must be 
monitored carefully. If this is ineffective, intravenous 
aminophylline should be used, 5 to 6 mg/kg body 
weight, no more rapidly than 50 mg/min ( 10). 
Aerosolized sympathomimetics may be used 
also. or instead of parenteral drug. Again. the car­
diac rate, rhythm, and blood pressure must be mon­
itored since there is a significant systemic effect from 
most of these drugs. 
Most of these patients will be quite anxious and 
the temptation to sedate them is great. They are 
anxious because they are hypoxemic and dyspneic. 
Additionally, most bronchodilators have central ef­
fects which are stimulatory, increasing anxiety. Al­
though some patients can trigger bronchospastic epi­
sodes by anxiety, the use of tranquilizers or sedatives 
is exceedingly dangerous, thus these drugs should not 
be used. Patients with ROAD do not thrive in the 
average emergency room environment. They should 
be kept in a quiet area under constant supervision 
and frequently reassured that they are receiving ade­
quate care. If this, plus the above therapy is 
administered, most of these patients will not require 
admission. Several series have demonstrated that 
only 2% to 5% of all patients will require admission. 
The inpatient management of ROAD, phase 
three, covers only a very small percentage of the 
total population of patients at risk; however, if im­
properly treated during this phase, the mortality is 
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significant. The question is frequently asked as to 
which patients should be admitted. The following 
guidelines are useful: 
I. All patients with high normal or elevated 
PaCO,'s or low pH's, that is, less than 7.30, 
need admission. 
2. Patients with forced expiratory volume in one 
second (FEY,) of less than 0.5 liters. FEV,'s 
are sometimes difficult to measure and equip­
ment is not always readily available, there­
fore, alternate mechanisms to assess function 
are needed. McFadden (9) demonstrated that 
intercostal retraction related well to severe 
mechanical obstruction and usually dis­
appeared with FEV,'s greater than one liter. 
Rebuck (8) has shown that pulsus para­
doxicus of greater than 10 to 12 mm Hg 
systolic blood pressure correlated well with 
severe reduction in FEY,. Thus. the presence 
of retractions and paradox should indicate 
admission. 
3. Patients with prolonged attacks, that is. 
greater than 12 hours. 
4. Patients demonstrating physical exhaustion. 
5. Patients who fail to respond to phase two 
measures within four to six hours. 
6. Patients with falling Pa02 and rising PaC02 
with emergency room management. 
Once the decision to admit has been made, the 
severity of the situation will dictate the best area of 
the hospital for therapy. Generally, the ICU should 
be considered as the desired location. The scope of 
intensive care management is beyond this paper, but 
several points should be made (2. 4, 6 ): 
I. No sedatives. 
2. Continuous 0, therapy (best given by nasal 
cannula) to maintain Pa02, 60 to 70 mm Hg. 
3. Frequent arterial gases until the patient is 
clearly better. 
4. Continuous aminophylline 1.V. (0.9 
mg/kg/hr) after an initial loading dose (5.6 
mg/kg/20 min). 
5. Inhaled or subcutaneous sympathomimetic 
drugs, or both, using monitoring of cardiac 
rate, rhythm, and blood pressure as the con­
trolling factors. 
6. ECG monitoring. 
7. Adequate hydration, since these patients are 
almost invariably dehydrated, which causes 
difficulty in clearing trachea-bronchial secre­
tions. This initially will have to be intraven-
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ous. Various estimates of fluid deficit have 
been made; however, good data is not 
available. Inpatients with normal cardio­
vascular-renal mechanisms should have fluid 
therapy until their secretions are thin and 
easily cleared. 
8. Humidity therapy with warm moist air, if 
tolerated, will help to loosen secretions. 
9. Corticosteroid therapy is a major portion 
of the therapy and must be given in 
pharmacologic doses. Methylprednisolone, 
250 mg, I. V. Q4h, has been very valuable in 
this area. It is preferred because of less miner­
alocorticoid effect, plus a longer half life than 
hydrocortisone. There are other less well 
defined reasons for·the use of this drug. 
The other frequently asked question is, when 
should these patients be placed on continuous ven­
tilator support1 There are several guidelines which 
are used by most physicians caring for numbers of 
these patients. and these guidelines are based primar­
ily on arterial blood gas studies. If the PaCO, begins 
to rise above the normal range (greater than 45 mm 
Hg) or the pH falls below 7.30 with the above pro­
gram, these patients are at great risk for respiratory 
and cardiac arrest, therefore, we electively intubate 
and assist these patients. Marked depression in the 
level of consciousness from severe fatigue indicates 
the need for ventilatory assistance. Continued unre­
mitting bronchospasm with optimal therapy should 
also be considered an indication for ventilatory as­
sistance. 
In summary, reversible obstructive airways 
disease (ROAD) is a common respiratory problem. 
Proper education and outpatient management will 
almost always provide adequate care. However, some 
patients require more active therapy in emergency 
rooms or hospitals. Since almost all patients, prop­
erly treated, will survive to return to productive life, a 
well-planned, aggressive therapeutic approach is 
needed as outlined in this paper. 
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